The Quarterly Report is available on the SEC’s website at www.sec.gov under the Company’s filings.
Q1 2026 was a quarter of meaningful balance sheet growth, driven by the Company’s financing and M&A activities, including the closing of the
Balance Sheet Highlights
- Total assets increased to approximately
$26.0 million as ofMarch 31, 2026 , up 102% from approximately$12.87 million at year-end 2025 and up 193% year-over-year. - Shareholders’ equity grew to approximately
$12.6 million , up 61% from approximately$7.84 million at year-end 2025 and up 55% year-over-year. - Cash and cash equivalents ended the quarter at approximately
$14.4 million , up from$5.4 million at year-end 2025 and representing the largest cash balance in the Company’s history. - Net working capital improved to approximately
$5.1 million from$2.9 million at year-end 2025.
Revenue Growth
Q1 2026 revenue reflects the contribution from all three operating manufacturing and packaging subsidiaries, with SVM Machining contributing a partial period following its closing on
- Revenue for the three months ended
March 31, 2026 was approximately$682,000 , compared to $nil for the same period in 2025. - Q1 2026 revenue exceeded the Company’s entire FY2025 revenue of approximately
$590,000 in a single quarter. - On a sequential basis, revenue grew approximately 124% from approximately
$304,000 in the fourth quarter of 2025.
Subsequent Events
Subsequent to quarter-end, the Company executed several additional strategic initiatives:
- Formation of
NorthStrive Defense Tech LLC (“NorthStrive Defense”) onApril 2, 2026 , a company that will focus on identifying, acquiring, and commercializing advanced defense technologies, with an emphasis on drone and autonomous systems. Following this formation, NorthStrive Defense signed two agreements with the option to acquire a patented GPS-denied autonomous drone navigation technology and multi-domain drone payload technology designed for air and water operations. - Entry into a new
$40 million equity purchase facility with an institutional investor onApril 17, 2026 , with an initial tranche of approximately$10 million funded at closing. The Company may draw additional amounts at its sole discretion over a 24-month commitment period. This facility will provide the Company with committed, flexible capital to continue executing on its active M&A pipeline currently focused on aerospace, defense, and industrial manufacturing. - Closing of the acquisition of
A&B Aerospace, Inc. (“A&B Aerospace”) onMay 12, 2026 .A&B Aerospace is a precision machining and aerospace manufacturing company based inCalifornia , serving Tier 1 customers, including Boeing, Honeywell, and Moog. A&B generated approximately$4.5 million in trailing-twelve-month revenue and is cash-flow positive.
About
Forward-Looking Statements
Statements contained in this press release regarding matters that are not historical facts are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Words such as “believes,” “expects,” “plans,” “potential,” “would” and “future” or similar expressions such as “look forward” are intended to identify forward-looking statements. Forward-looking statements are made as of the date of this press release and are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy, activities of regulators and future regulations and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results. Therefore, you should not rely on any of these forward-looking statements. These and other risks are described more fully in PMGC’s filings with the
IR Contact: IR@pmgcholdings.com
Source: 